AstraZeneca beats Street EPS

AstraZeneca (LSE:AZN; AZN) reported second quarter EPS of $0.39, beating by $0.06 the Street's $0.33 consensus estimate. The EPS

Read the full 196 word article

How to gain access

Continue reading with a
two-week free trial.